adaura: the benefit of adjuvant osimertinib
Published 4 years ago • 156 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
3:30
adaura: osimertinib adjuvant therapy on cns disease recurrence
-
3:13
updates from adaura: continued dfs benefit with osimertinib vs. placebo
-
2:13
overall-survival analysis of adaura: osimertinib in resected egfrm stage ib-iiia nsclc
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
4:24
reflections on the adaura study
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
1:08
adaura clinical trial update
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
8:06
adaura: osimertinib post-tumor resection in nsclc
-
10:20
role of adjuvant osimertinib in early stage nsclc
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
4:58
discussion on the adaura study
-
4:25
adaura: osimertinib as adjuvant therapy in stage iii egfr nsclc
-
11:37
asco23 - lba3: os analysis from the adaura trial of adjuvant osimertinib in resected egfr‐mutate...
-
6:23
adaura trial; early stage non–small cell lung cancer
-
1:37
dr. levy on the dfs benefit achieved with adjuvant osimertinib in egfr nsclc
-
2:12
esmo 2020 highlights on adjuvant osimertinib for egfr mutated nsclc: the adaura study